The Vyta.co difference

You bought the medication.
We built the clinic.

A medication this serious deserves a clinic that treats it that way — with real monitoring, real clinicians, and a platform built for the work. Most telehealth clinics ship the pen and disappear. We built Vyta.co for patients who expect their clinician to be paying attention.

Start your evaluation See the platform →
The platform

One clinic. Built around you.
Your care, in real time.

Vyta.co clinicians don't work from a generic EMR patched together with spreadsheets. They work from a tool we built, for this medication, for this moment.

Start your evaluation
Vyta.co clinician dashboard — patient panel
The clinician view

Your clinician has the full picture.

Weight, body fat, dose history, side-effect logs, injection sites — every datapoint your clinician needs to titrate, flag, and personalize, in a single pane. No faxing. No patchwork tools. No missed signals.

Patient Roster Cohort Messages
LIVE · 09:42 EDT
73
Harper Odinga
Low risk
63 yrs · Female · Patient P017 · Semaglutide · 2.4mg @ 5mg/mL · 49 wks on therapy
316.5 lb → 263.8 lb −52.7 lb · 38% → 31.7% BF −6.3%
Weight & body fat trajectory
Triangles = injections · Dashed lines = dose escalations
Weight (lb) BF %
316.1 289.8 274.8 259.8 38.7% 35.7% 32.7% 29.7% W0 W6 W12 W18 W24 W30 W36 W42 W48
Cohort percentile
Momentum score 98p
BF% lost 94p
BF% lost per mg 56p
✶ Auto insights
No logs in 8 days — consider outreach.
Rapid initial response: 6.3% BF lost in first 8 weeks.
Patient currently ranks in 56th percentile for BF%/mg efficiency.
Injection log
49 injections · titration shown in accent rows
DateCompoundUnitsConc.Mg doseSite
Apr 14, 2026Semaglutide485 mg/mL2.4 mgR abdomen
Apr 5, 2026Semaglutide485 mg/mL2.4 mgR thigh
Mar 31, 2026Semaglutide485 mg/mL2.4 mgL abdomen
Mar 17, 2026Semaglutide485 mg/mL2.4 mg ↑L thigh
Mar 10, 2026Semaglutide345 mg/mL1.7 mgR abdomen
01
Risk ring — composite score from adherence, side-effects, and trajectory.
02
Every injection plotted — site rotation, units, concentration, timing.
03
Cohort percentile — benchmarked against 200+ active patients.
04
Auto insights — the AI flags what needs a clinician's attention, now.
Start your evaluation See how the AI works →
The AI layer

A co-pilot for your clinician.

Four capabilities running continuously in the background — so your clinician spends their time on you, not on spreadsheets.

01 · Plateau prediction
Flag plateaus before they happen.
Your trajectory is modeled against thousands of similar journeys. When a plateau looks likely, we intervene — weeks before the scale stops moving.
FORECAST · 6W AHEAD
Plateau risk ↑
NOW
02 · Dose optimization
Personalized titration, not a protocol.
The model recommends dose adjustments informed by your side-effect log, weight velocity, and cohort response — your clinician approves every one.
RECOMMENDED · NEXT WEEK
2.4MG · WEEKLY
0.25 mg
0.5 mg
1.0 mg
1.7 mg
2.4 mg — now
03 · Cohort analysis
Your journey, against thousands.
Patterns invisible to a single clinic become visible across ours. What worked for someone who looks like you, 6 months ahead of you, informs your care today.
204 ACTIVE · SIMILAR COHORT
YOU
04 · Individualized care plan
One plan. Built for you.
All four streams converge into a weekly plan your clinician reviews and sends — dose, nutrition focus, side-effect watch, lab timing.
PLAN · WEEK 50
Dose2.4 mg
SiteR thigh
Protein92 g/d
Hydration2.4 L
WatchNausea
LabsJun 14
The close

This isn't telehealth.
This is precision weight care.

A medication this serious deserves a clinic that treats it that way — with real monitoring, real clinicians, and a platform built for the work.

Start your evaluation
Patient
Harper Odinga
W49 · −52.7 lb · 2.4mg semaglutide
Data · always
Clinician
Dr. John Venzor
FL-licensed · 14 yrs metabolic · Vyta.co roster
Premium monitoring for a premium medication.